Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Guidelines and Strategies for Safe Computer Charting

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Implementing an accelerated three-year MD curriculum at NYU Grossman School of Medicine.

Medical teacher·2024

Same author

Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.

The Journal of infectious diseases·2024

Same author

Serum proteomic panel validated for prediction of knee osteoarthritis progression.

Osteoarthritis and cartilage open·2023

Same author

Pathological tissue formation and degradation biomarkers correlate with patient reported pain outcomes: an explorative study.

Osteoarthritis and cartilage open·2023

Same author

Interleukin-1 receptor antagonist gene ( <i>IL1RN</i> ) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2.

medRxiv : the preprint server for health sciences·2023

Same author

Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis.

Cells·2022

Search research articles

Related Experiment Videos

Clinical guidelines: Expert recommendations for NSAID use: a user-friendly model?

Steven B Abramson¹

¹Department of Medicine and Pathology, NYU Langone Medical Center, 550 First Avenue, New York, NY 10022, USA. stevenb.abramson@nyumc.org.

Nature Reviews. Rheumatology

|January 26, 2011

Summary

Balancing the risks and benefits of nonsteroidal anti-inflammatory drugs (NSAIDs) poses a challenge for millions. A new web-based tool may help physicians make better treatment decisions for improved patient care.

Related Experiment Videos

Area of Science:

Pharmacology
Clinical Medicine
Health Informatics

Background:

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used globally.
Balancing the therapeutic benefits against the risks of NSAIDs remains a clinical challenge.
Existing evidence-based guidelines and expert opinions may not fully translate into improved patient outcomes.

Discussion:

Physician decision-making regarding NSAID use requires support.
Translating complex risk-benefit analyses into clinical practice is difficult.
The integration of clinical evidence into daily practice is crucial for effective patient management.

Key Insights:

A novel web-based tool is introduced to assist physicians.
This tool aims to support informed treatment decisions for NSAID therapy.
The tool could bridge the gap between guidelines and clinical application.

Outlook:

The tool has the potential to enhance the application of evidence-based medicine.
Improved clinical decision support may lead to better patient care outcomes.
Future research should evaluate the tool's impact on patient safety and efficacy.